INSP logo

Inspire Medical Systems, Inc. Stock Price

NYSE:INSP Community·US$1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 23 Fair Values set on narratives written by author

INSP Share Price Performance

US$50.50
-77.00 (-60.39%)
US$52.17
Fair Value
US$50.50
-77.00 (-60.39%)
3.2% undervalued intrinsic discount
US$52.17
Fair Value
Price US$50.50
AnalystConsensusTarget US$52.17
AnalystHighTarget US$64.36
AnalystLowTarget US$39.00

INSP Community Narratives

·
Fair Value US$52.17 3.2% undervalued intrinsic discount

Sector Dislocations And Transitory Headwinds Will Create Long-Term Upside Opportunity

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value US$64.36 21.5% undervalued intrinsic discount

Telemedicine Integration Will Expand Sleep Apnea Solutions For Aging Populations

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$39 29.5% overvalued intrinsic discount

Budget Pressures And Rollout Delays Will Constrain Sleep Healthcare Prospects

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$39
29.5% overvalued intrinsic discount
Revenue
-0.26% p.a.
Profit Margin
5.15%
Future PE
26.91x
Price in 2029
US$47.24

Trending Discussion

No trending discussion available.

Updated Narratives

INSP logo

INSP: Prolonged Coding Uncertainty Will Pressure Returns Despite Neurostimulation Opportunity

Fair Value: US$39 29.5% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
INSP logo

INSP: Coding Clarity And Reimbursement Progress Will Drive Future Stock Repricing

Fair Value: US$64.36 21.5% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
INSP logo

INSP: CMS Coding Progress Will Gradually Support Future Reimbursement And Earnings Power

Fair Value: US$52.17 3.2% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

2 Risks
3 Rewards

Inspire Medical Systems, Inc. Key Details

US$915.2m

Revenue

US$130.2m

Cost of Revenue

US$785.1m

Gross Profit

US$653.9m

Other Expenses

US$131.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 03, 2026
4.55
85.78%
14.33%
0%
View Full Analysis

About INSP

Founded
2007
Employees
1333
CEO
Timothy Herbert
WebsiteView website
www.inspiresleep.com

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Recent INSP News & Updates

Recent updates

No updates